Immune Checkpoint Therapy—Current Perspectives and Future Directions

Scientists highlight the biology of anti-tumor immunity underlying response and resistance to immune checkpoint therapy (ICT), discuss efforts to address the current challenges with ICT, and outline strategies to guide the development of subsequent clinical trials and combinatorial efforts with ICT.